{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T21:10:15Z","timestamp":1760908215318},"reference-count":17,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2005,7,7]],"date-time":"2005-07-07T00:00:00Z","timestamp":1120694400000},"content-version":"vor","delay-in-days":6,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J Paediatrics Child Health"],"published-print":{"date-parts":[[2005,7]]},"abstract":"<jats:p><jats:bold>Abstract:\u2003<\/jats:bold> Two patients, a 4\u2010year\u2010old boy and a 6\u2010year\u2010old girl who had a 2\u2010year and a 3\u2010year history of idiopathic thrombocytopenic purpura, respectively, were referred to our Department. Both patients had frequent haemorrhagic events. They received i.v. immunoglobulin, corticosteroids, cyclosporine, interferon \u03b1\u20102b and azathioprine, but no clinical remission was established. The girl also underwent splenectomy. Anti\u2010CD20 antibody was administered to both patients at a dose of 375\u2003mg\/m<jats:sup>2<\/jats:sup> once weekly for 4 weeks. No side\u2010effects were detected. During the 18\u2010month follow\u2010up period the patients received no other drug and remained in clinical remission. The B lymphocytes remained undetectable in peripheral blood for 3 months and they progressively increased during the following 4 months. Rituximab is a novel, quite effective, safe treatment of chronic refractory idiopathic thrombocytopenic purpura in childhood. More studies and follow up of patients for longer periods are necessary.<\/jats:p>","DOI":"10.1111\/j.1440-1754.2005.00641.x","type":"journal-article","created":{"date-parts":[[2005,7,7]],"date-time":"2005-07-07T11:36:29Z","timestamp":1120736189000},"page":"384-386","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Clinical remission following monoclonal anti\u2010CD20 therapy in two children with chronic refractory idiopathic thrombocytopenic purpura"],"prefix":"10.1111","volume":"41","author":[{"given":"Maria","family":"Moschovi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgios","family":"Trimis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helini","family":"Pergantou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heleni","family":"Platokouki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleni","family":"Vrachnou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fotini","family":"Tzortzatou\u2010Stathopoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,7,7]]},"reference":[{"key":"e_1_2_4_2_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001813-200211002-00002"},{"key":"e_1_2_4_3_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001813-200211002-00005"},{"key":"e_1_2_4_4_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.10947"},{"key":"e_1_2_4_5_2","first-page":"1209","article-title":"Rituximab: An anti\u2010CD20 antibody for the treatment of chronic refractory immune thrombocytopenic purpura","volume":"95","author":"Aggrarwal A","year":"2002","journal-title":"South. Med. J."},{"key":"e_1_2_4_6_2","first-page":"421","article-title":"Rituximab treatment of chronic idiopathic thrombocytopenic purpura. Results of a phase II study","volume":"93","author":"Meo P","year":"2002","journal-title":"Recent Prog. Med."},{"key":"e_1_2_4_7_2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdg175"},{"key":"e_1_2_4_8_2","first-page":"538","article-title":"B\u2010cell compartment as the selective target for the treatment of immune thrombocytopenias","volume":"88","author":"Zaja F","year":"2003","journal-title":"Haematologica"},{"key":"e_1_2_4_9_2","doi-asserted-by":"publisher","DOI":"10.1078\/0171-2985-00200"},{"key":"e_1_2_4_10_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.4.952"},{"key":"e_1_2_4_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.thj.6200148"},{"key":"e_1_2_4_12_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-02-0392"},{"key":"e_1_2_4_13_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-09-2856"},{"key":"e_1_2_4_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdf350"},{"key":"e_1_2_4_15_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200306263482619"},{"key":"e_1_2_4_16_2","doi-asserted-by":"publisher","DOI":"10.1086\/345746"},{"key":"e_1_2_4_17_2","first-page":"22","article-title":"Fulminant hepatitis subsequent to reactivation of precore mutant hepatitis B virus in a patient with lymphoma treated with chemotherapy and rituximab","volume":"88","author":"Hernandez JA","year":"2003","journal-title":"Haematologica"},{"key":"e_1_2_4_18_2","doi-asserted-by":"publisher","DOI":"10.1078\/0171-2985-00200"}],"container-title":["Journal of Paediatrics and Child Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1440-1754.2005.00641.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1440-1754.2005.00641.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T10:35:04Z","timestamp":1696934104000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1440-1754.2005.00641.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7]]},"references-count":17,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2005,7]]}},"alternative-id":["10.1111\/j.1440-1754.2005.00641.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1440-1754.2005.00641.x","archive":["Portico"],"relation":{},"ISSN":["1034-4810","1440-1754"],"issn-type":[{"value":"1034-4810","type":"print"},{"value":"1440-1754","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,7]]},"assertion":[{"value":"2005-07-07","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}